Peking Union Medical College Hospital
Clinical trials sponsored by Peking Union Medical College Hospital, explained in plain language.
-
Precision radiation may cut side effects in cervical cancer
Disease control OngoingThis study tests online adaptive radiotherapy, a type of radiation that adjusts in real-time to target cervical cancer more precisely. By using smaller treatment margins, doctors hope to reduce side effects while still effectively treating the tumor. The trial involves 30 adults …
Phase: PHASE1, PHASE2 • Sponsor: Peking Union Medical College Hospital • Aim: Disease control
Last updated Jun 27, 2026 13:05 UTC
-
Abandoned trial: could a platelet booster help aplastic anemia?
Disease control TerminatedThis study planned to test the drug hetrombopag in people with non-severe aplastic anemia, a condition where the bone marrow doesn't make enough blood cells. The goal was to see if the drug could safely raise platelet counts. However, the trial was withdrawn before enrolling any …
Phase: PHASE2, PHASE3 • Sponsor: Peking Union Medical College Hospital • Aim: Disease control
Last updated Jun 27, 2026 13:05 UTC
-
Aplastic anemia drug combo study pulled before starting
Disease control TerminatedThis study was designed to test whether combining cyclosporine with drugs that boost platelet production (eltrombopag, hetrombopag, or romiplostim) could help people with newly diagnosed severe aplastic anemia who need blood transfusions. The trial was withdrawn before enrolling …
Phase: PHASE2 • Sponsor: Peking Union Medical College Hospital • Aim: Disease control
Last updated Jun 27, 2026 13:04 UTC
-
Promising combo for aplastic anemia trial pulled before start
Disease control TerminatedThis trial aimed to compare the safety and effectiveness of adding luspatercept to cyclosporine versus cyclosporine alone in adults newly diagnosed with non-severe aplastic anemia (NSAA). The goal was to see if the combination could improve blood cell counts better than the stand…
Phase: PHASE4 • Sponsor: Peking Union Medical College Hospital • Aim: Disease control
Last updated Jun 27, 2026 13:03 UTC
-
Abandoned trial: drug for Treatment-Related anemia never tested
Disease control TerminatedThis study was designed to test whether romiplostim N01 could help people with aplastic anemia caused by chemotherapy or radiation therapy. The trial was withdrawn before enrolling any participants, so no results are available. It was planned as a small, early-stage study at a si…
Phase: PHASE2 • Sponsor: Peking Union Medical College Hospital • Aim: Disease control
Last updated Jun 27, 2026 13:03 UTC
-
Promising combo for aplastic anemia trial pulled before start
Disease control TerminatedThis study was designed to test whether adding enarodustat to cyclosporine helps people with a type of aplastic anemia who need regular blood transfusions. The trial was withdrawn before enrolling any participants, so no results are available. It would have compared the combinati…
Phase: PHASE3 • Sponsor: Peking Union Medical College Hospital • Aim: Disease control
Last updated Jun 27, 2026 13:02 UTC
-
New device aims to prevent vaginal scarring after cancer radiation
Disease control ENROLLING_BY_INVITATIONThis study tests a special device that combines a vaginal dilator with a drug delivery tube to help prevent vaginal narrowing and scarring after pelvic radiation therapy. About 76 women aged 18-70 who have completed radiation for pelvic tumors will use the device regularly. The g…
Phase: NA • Sponsor: Peking Union Medical College Hospital • Aim: Disease control
Last updated Jun 27, 2026 11:02 UTC
-
New RNA drug hopes to slow duchenne muscle loss
Disease control OngoingThis early-phase trial tests a new drug called RAG-18 in 12 boys aged 4-15 with Duchenne muscular dystrophy. The drug is a small activating RNA given through an IV, designed to help muscles work better. The main goal is to check safety and how the body handles the drug, with earl…
Phase: EARLY_PHASE1 • Sponsor: Peking Union Medical College Hospital • Aim: Disease control
Last updated Jun 27, 2026 08:12 UTC
-
New Dual-Action drug targets Hard-to-Treat kidney cancer
Disease control TerminatedThis early-stage study tests a new drug called NYM096 in people with advanced clear cell kidney cancer that has spread. The study has two parts: first, using a low dose to see if it can light up tumors on scans, and second, giving higher doses to see if it can shrink tumors and f…
Phase: PHASE1 • Sponsor: Peking Union Medical College Hospital • Aim: Disease control
Last updated Jun 27, 2026 08:07 UTC
-
New procedure shrinks giant goiters without surgery
Disease control ENROLLING_BY_INVITATIONThis study tests a new, less invasive treatment for large thyroid nodules (giant nodular goiter) that cause discomfort or breathing problems. The procedure uses a tiny tube to deliver a chemotherapy drug (bleomycin) directly into the nodule's blood supply, blocking it and shrinki…
Phase: NA • Sponsor: Peking Union Medical College Hospital • Aim: Disease control
Last updated Jun 27, 2026 08:01 UTC
-
Robot vs. doctor: new trial pits machine against human for brain scans
Disease control OngoingThis study compares a robotic system to traditional manual methods for performing cerebral angiography, a procedure that images blood vessels in the brain. Researchers will enroll 450 patients aged 18-75 with suspected head or neck vascular issues. The goal is to see if the robot…
Phase: NA • Sponsor: Peking Union Medical College Hospital • Aim: Disease control
Last updated Jun 27, 2026 07:51 UTC
-
Battle of the stents: which drainage method wins for bile duct cancer?
Disease control OngoingThis study compares two endoscopic procedures—EUS-BD and ERCP-BD—for draining blocked bile ducts caused by cancers near the pancreas or bile duct. Forty adults with distal malignant bile duct obstruction will be randomly assigned to one of the two procedures. The main goal is to …
Phase: NA • Sponsor: Peking Union Medical College Hospital • Aim: Disease control
Last updated Jun 26, 2026 13:34 UTC
-
New scan could spot pituitary tumors more clearly
Diagnosis ENROLLING_BY_INVITATIONThis early-phase study tests a new radioactive tracer called [68Ga]Ga-NOTA-RF for PET scans in 30 people with pituitary tumors. The goal is to see if this tracer can better highlight tumors and help doctors tell different tumor types apart. Participants receive an injection of th…
Phase: EARLY_PHASE1 • Sponsor: Peking Union Medical College Hospital • Aim: Diagnosis
Last updated Jun 27, 2026 08:00 UTC
-
New radiation technique aims to cut side effects for uterine cancer patients
Symptom relief OngoingThis study tests a newer type of radiation therapy called online adaptive radiotherapy (oART) for people who have had surgery for endometrial or cervical cancer. The goal is to see if using smaller treatment margins can reduce side effects while still effectively targeting any re…
Phase: PHASE1, PHASE2 • Sponsor: Peking Union Medical College Hospital • Aim: Symptom relief
Last updated Jun 27, 2026 13:05 UTC
-
Can a simple pill ease gagging during a throat scope? new study explores ondansetron for EGD comfort.
Symptom relief OngoingThis pilot study tests whether taking ondansetron, a common anti-nausea drug, before an unsedated throat scope (EGD) can reduce gagging, nausea, and overall discomfort. About 40 Chinese patients who have had this exam before will either receive ondansetron plus a numbing gargle, …
Phase: PHASE4 • Sponsor: Peking Union Medical College Hospital • Aim: Symptom relief
Last updated Jun 27, 2026 12:28 UTC
-
AI tutor put to the test: will it sharpen future Doctors' clinical skills?
Knowledge-focused ENROLLING_BY_INVITATIONThis study tests whether an AI training agent can improve medical students' clinical reasoning skills compared to traditional study materials. About 88 students from two Chinese medical schools will be randomly assigned to use either the AI tool or standard case materials. Resear…
Phase: NA • Sponsor: Peking Union Medical College Hospital • Aim: Knowledge-focused
Last updated Jun 27, 2026 13:00 UTC
-
3D-Printed tumors could revolutionize liver cancer drug matching
Knowledge-focused OngoingThis study explores whether 3D bioprinting can create personalized models of liver cancer from a patient's own tumor tissue. Researchers will test different drugs on these models to see which ones work best, aiming to predict a patient's response before treatment. The goal is to …
Sponsor: Peking Union Medical College Hospital • Aim: Knowledge-focused
Last updated Jun 27, 2026 09:09 UTC
-
1000 stroke patients join study to map brain recovery
Knowledge-focused OngoingThis study follows 1000 adults who have had a stroke to better understand how the brain recovers. Researchers use brain scans, electrical signals, and physical tests to find patterns linked to recovery. The goal is to improve predictions and treatments for stroke survivors.
Sponsor: Peking Union Medical College Hospital • Aim: Knowledge-focused
Last updated Jun 27, 2026 09:06 UTC
-
New study aims to personalize cervical cancer treatment after radiation
Knowledge-focused OngoingThis study follows 60 people with cervical adenocarcinoma to see how their tumors respond to radiotherapy. Researchers will use imaging and tissue samples to better predict outcomes and guide next steps, like surgery or additional treatment. The goal is to improve monitoring and …
Phase: PHASE1, PHASE2 • Sponsor: Peking Union Medical College Hospital • Aim: Knowledge-focused
Last updated Jun 26, 2026 14:13 UTC
-
3,000 women surveyed to boost breast cancer early detection
Knowledge-focused OngoingThis study surveys 3,000 women aged 40 and older in Chinese communities to understand how aware they are of breast self-exams and how often they do them. Using a health belief model, researchers will look at what factors influence these practices. The goal is to find gaps between…
Sponsor: Peking Union Medical College Hospital • Aim: Knowledge-focused
Last updated Jun 26, 2026 13:03 UTC